CH554863A - Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten. - Google Patents

Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.

Info

Publication number
CH554863A
CH554863A CH783768A CH783768A CH554863A CH 554863 A CH554863 A CH 554863A CH 783768 A CH783768 A CH 783768A CH 783768 A CH783768 A CH 783768A CH 554863 A CH554863 A CH 554863A
Authority
CH
Switzerland
Prior art keywords
methyl
hydroxy
hydroxymethyl
pyridine
acid
Prior art date
Application number
CH783768A
Other languages
German (de)
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CH554863A publication Critical patent/CH554863A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH783768A 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten. CH554863A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1695428A DE1695428C3 (de) 1967-06-08 1967-06-08 Derivate des 5-Mercaptopyridoxins und Verfahren zu deren Herstellung
DE19681770222 DE1770222A1 (de) 1967-06-08 1968-04-18 Neue schwefelhaltige Pyridinderivate

Publications (1)

Publication Number Publication Date
CH554863A true CH554863A (de) 1974-10-15

Family

ID=25755557

Family Applications (9)

Application Number Title Priority Date Filing Date
CH1609470A CH565764A5 (xx) 1967-06-08 1968-05-28
CH391773A CH565765A5 (xx) 1967-06-08 1968-05-28
CH1609370A CH551973A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH787368D CH560192A5 (xx) 1967-06-08 1968-05-28
CH391573A CH555827A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH1609570A CH552590A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH783768A CH554863A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH1609270A CH551972A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH783768A CH560191A5 (xx) 1967-06-08 1968-05-28

Family Applications Before (6)

Application Number Title Priority Date Filing Date
CH1609470A CH565764A5 (xx) 1967-06-08 1968-05-28
CH391773A CH565765A5 (xx) 1967-06-08 1968-05-28
CH1609370A CH551973A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH787368D CH560192A5 (xx) 1967-06-08 1968-05-28
CH391573A CH555827A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH1609570A CH552590A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1609270A CH551972A (de) 1967-06-08 1968-05-28 Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
CH783768A CH560191A5 (xx) 1967-06-08 1968-05-28

Country Status (10)

Country Link
US (2) US3625949A (xx)
JP (1) JPS5250793B1 (xx)
AT (2) AT278792B (xx)
CH (9) CH565764A5 (xx)
DE (2) DE1695428C3 (xx)
ES (1) ES354787A1 (xx)
FR (1) FR7678M (xx)
GB (1) GB1156769A (xx)
NL (1) NL155730B (xx)
SE (1) SE346995B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310130A1 (fr) * 1975-05-09 1976-12-03 Merck & Co Inc Alcanesulfonates de 5-mercaptopyridoxine

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046897A (en) * 1975-05-09 1977-09-06 Merck & Co., Inc. 5-Mercaptopyridoxine alkanesulfonates and methods of use and pharmaceutical compositions
CA2900181C (en) 2003-08-06 2019-01-29 Catherine Tachdjian Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
US20060045953A1 (en) * 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
RU2410383C2 (ru) * 2005-02-04 2011-01-27 Синомикс, Инк. Соединения, включающие связанные гетероарильные фрагменты, и их применение в качестве новых модификаторов вкусо-аромата умами, тастантов (стимуляторов сенсорных клеток вкусовых сосочков языка) и усилителей вкуса в пищевых композициях
WO2006084184A2 (en) * 2005-02-04 2006-08-10 Senomyx, Inc. Molecules comprising linked organic moieties as flavor modifiers for comestible compositions
AR055329A1 (es) * 2005-06-15 2007-08-15 Senomyx Inc Amidas bis-aromaticas y sus usos como modificadores de sabor dulce, saborizantes, y realzadores de sabor
US8148536B2 (en) 2006-04-21 2012-04-03 Senomyx, Inc. Comestible compositions comprising high potency savory flavorants, and processes for producing them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633927A (xx) * 1958-03-21

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310130A1 (fr) * 1975-05-09 1976-12-03 Merck & Co Inc Alcanesulfonates de 5-mercaptopyridoxine

Also Published As

Publication number Publication date
DE1695428B2 (de) 1978-02-02
NL155730B (nl) 1978-02-15
CH555827A (de) 1974-11-15
ES354787A1 (es) 1969-11-01
AT278792B (de) 1970-02-10
CH565764A5 (xx) 1975-08-29
CH552590A (de) 1974-08-15
CH551972A (de) 1974-07-31
DE1695428C3 (de) 1978-10-05
US3625949A (en) 1971-12-07
DE1770222A1 (de) 1971-11-11
FR7678M (xx) 1970-02-16
CH560192A5 (xx) 1975-03-27
AT278793B (de) 1970-02-10
CH560191A5 (xx) 1975-03-27
NL6808029A (xx) 1968-12-09
DE1695428A1 (de) 1971-04-15
JPS5250793B1 (xx) 1977-12-27
CH565765A5 (xx) 1975-08-29
US3755336A (en) 1973-08-28
SE346995B (xx) 1972-07-24
CH551973A (de) 1974-07-31
GB1156769A (en) 1969-07-02

Similar Documents

Publication Publication Date Title
DE2647907C2 (de) 2-Phenyl-3-aroylbenzothiophene und Verfahren zu ihrer Herstellung
DE2141634C3 (de) Neue Isoindolinderivate, ihre Herstellung und Zusammensetzungen, die sie enthalten
DE2166381C3 (de) γ-Piperidinobutyrophenonderivate, Verfahren zu i hrer Herstellung und Arzneipräparate
CH554863A (de) Verfahren zur herstellung von neuen schwefelhaltigen pyridinderivaten.
DE3040727A1 (de) "flavane und ihre saeureadditionssalze"
DE2426149B2 (de) 7-Fluor-substituierte Phenothiazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE2036027C3 (de) Pleuromutilin-Derivate und Verfahren zu ihrer Herstellung
DE3426533A1 (de) 1,3,4-thiadiazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3618711A1 (de) 2-alkyl oder aralkyl-thio-1-cycloalken-1-carboxamide und ihre sulfoxide, verfahren zu ihrer herstellung und ihre verwendung zur synthese von 4,5-tri- und tetramethylen-4-isothiazolin-3-on
DE2060386A1 (de) Benzolsulfonsaeuren und Verfahren zu deren Herstellung
DE2335507C2 (de) Sulfamylbenzoesäurederivate, Verfahren zu deren Herstellung und sie enthaltendes pharmazeutisches Mittel
DE1620747C3 (de) Carbothiamin sowie dessen nichttoxische organische oder anorganische Säureadditionssalze sowie Verfahren zur Herstellung dieser Verbindungen
EP0170926B1 (de) In der 9- oder 11-Stellung eine, gegebenenfalls substituierte, Aminogruppe aufweisende Eburnancarbonsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2430510C3 (de) 16,17-Dihydroapovincaminsäureamide, Verfahren zu deren Herstellung und Arzneimittel, welche diese Verbingungen enthalten
DD235646A5 (de) Verfahren zur herstellung von neuen aminoeburnancarbonsaeure-derivaten
DE1670539C3 (de) Diacylthiamine und Verfahren zu deren Herstellung
DE1812794C3 (de) 2-Methyl-3-hydroxy-5-methylthiomethylpyridinderivate und Verfahren zu deren Herstellung
AT362353B (de) Verfahren zur herstellung von neuen in 4- -stellung substituierten 3-sulfamoyl-5-pyrrolyl - oder -5-pyrrolylalkylbenzoesaeuren und ihren salzen
DE1187236B (de) Verfahren zur Herstellung von 17beta-Aminosteroiden
DE1620749C3 (de) Verfahren zur Herstellung von Carbothiamin
DE2508251A1 (de) Neue derivate des indols, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
AT211816B (de) Verfahren zur Herstellung von neuen polyjodierten Benzoylverbindungen
AT250365B (de) Verfahren zur Herstellung von neuen Sulfamyl-3, 4-dihydro-1, 2, 4-benzothiadiazin-1, 1-dioxyden
AT332408B (de) Verfahren zur herstellung neuer chinolinverbindungen und ihrer salze
AT346828B (de) Verfahren zur herstellung von neuen benzhydrylsulfinylalkylamidinen

Legal Events

Date Code Title Description
PL Patent ceased